Byron Chemical Company, Inc. is a privately held firm, established in 1947. We operate within the pharmaceutical industry as sales, marketing, and regulatory agents for international manufactures.
Byron has established two groups: a group specializing in active pharmaceutical ingredients (APIs) and a group specializing in finished dose products (FDP). Byron has determined that because of the very different needs customers have in these two areas, expert attention is necessary. The API group includes Jake Ter Avest, Victor Rosenzweig and Adria Keleman. The FDP group includes Dwayne Sharpe and Nicholas Cola.
As sales and regulatory agents, we facilitate the entire product import and distribution process, maintaining compliance with applicable regulations.
United States
![β-Alanine,N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-(211914-51-1)](http://www.lookchem.com/300w/2010/0620/211914-51-1.jpg)
![1H-Benzimidazole,2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt(1:1)(117976-90-6)](http://file1.lookchem.com/cas/reactions/2021/07/02/7561607.png)
